Applied Work

Examples of my current projects and published applied work.

Current work: SART IVF prediction models

Within CHIRP, I am contributing to an update of the IVF prediction models developed for the Society for Assisted Reproductive Technology (SART). This ongoing work focuses on evaluating and revising models used to estimate IVF outcomes.

Cardiac Resynchronization Therapy (CRT)

Sudesh S, Abraham WT, Cleland JG, Curtis AB, Friedman DJ, Gold MR, Kutyifa V, Linde C, Tang AS, Olivas-Martinez A, Inoue LYT. Cardiac resynchronization therapy in ischemic versus nonischemic cardiomyopathy: patient-level meta-analysis of 7 randomized clinical trials. Heart Failure. 2024;12(11):1915–24. DOI
Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders SD, Al-Khatib SM. Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis. J Am Heart Assoc. 2024;13(15):e031785. DOI
Friedman DJ, Olivas-Martinez A, Dalgaard F, Fudim M, Abraham WT, Cleland JG, Curtis AB, Gold MR, Kutyifa V, Linde C, Tang AS. Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of randomized controlled trials. Heart Rhythm. 2024;21(6):845–54. DOI
Fudim M, Dalgaard F, Friedman DJ, Abraham WT, Cleland JG, Curtis AB, Gold MR, Kutyifa V, Linde C, Ali-Ahmed F, Tang A, Olivas-Martinez A, Inoue LYT, Al-Khatib SM, Sanders GD. Comorbidities and clinical response to cardiac resynchronization therapy: patient-level meta-analysis from eight clinical trials. Eur J Heart Fail. 2024;1039–46. DOI
Zeitler EP, Dalgaard F, Abraham WT, Cleland JG, Curtis AB, Friedman DJ, Gold MR, Kutyifa V, Linde C, Tang AS, Olivas-Martinez A. Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis. Am Heart J. 2024;267:81–90. DOI
Dalgaard F, Fudim M, Al-Khatib SM, Friedman DJ, Abraham WT, Cleland JG, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Ali-Ahmed F, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD. Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials. J Cardiovasc Electrophysiol. 2023;34(9):1914–24. DOI
Friedman DJ, Al-Khatib SM, Dalgaard F, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Tang AS, Ali-Ahmed F, Olivas-Martinez A, Inoue LYT, Sanders GD. Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials. Circulation. 2023;147(10):812–823. DOI

COVID-19 Research in Mexico

Hedlin H, Tobback E, Lee J, Wang Y, Dragoni I, Anthony DC, Dhaliwal K, Norrie J, Halford S, Gotes J, Moctezuma M, Olivas-Martinez A, et al. Individual Patient Data Meta-Analysis evaluating Camostat Mesilate to Treat COVID-19 in Community Settings. medRxiv. 2024. medRxiv
Azamar-Llamas A, Arenas-Martinez JS, Olivas-Martinez A, et al. Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico. PLoS One. 2024;19(3):e0301198. DOI
Corona-Rodarte E, Olivas-Martinez A, Solis-Pompa R, Cano-Aguilar LE, Asz-Sigall D, Ferrusco-Ontiveros MD, Soto-Ortiz JA, Burgos-Mora L. Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID-19 pandemic in a reference centre in Mexico. JEADV. 2023. DOI
Gasca NC, Reyes-Garza J, Lozano-Esparza S, Orozco-del Pino P, Olivas-Martinez A, Ulloa-Pérez E, Garbuno-Inigo A, Arroyo J. Effect of Mexico’s vaccination program on Covid-19 cases, hospitalizations, and deaths among older adults in Mexico City. Salud Publica Mex. 2022;64(4):424–428. DOI
Jimenez JV, Olivas-Martinez A, et al. Outcomes in temporary ICUs versus conventional ICUs: An observational cohort of mechanically ventilated patients with COVID-19–induced acute respiratory distress syndrome. Crit Care Explor. 2022;4(4):e0668. DOI
Servin-Rojas M, Olivas-Martinez A, et al. Impact of the COVID-19 pandemic on the clinical training of last year medical students in Mexico: a cross-sectional nationwide study. BMC Med Educ. 2022;22:24. DOI
Servin-Rojas M, Olivas-Martinez A, Ramirez-Del Val F, Torres-Gomez A, Navarro-Vargas L, García-Juárez I. Transplant trends in Mexico during the COVID-19 pandemic: Disparities within healthcare sectors. Am J Transplant. 2021;21(12):4052–60. DOI
Lozano-Cruz OA, Jiménez JV, Olivas-Martinez A, et al. Adverse effects associated with the use of antimalarials during the COVID-19 pandemic in a tertiary care center in Mexico City. Front Pharmacol. 2021;12:668678. DOI
Moctezuma-Velázquez O, Miranda-Zazueta G, Ortiz-Brizuela E, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, Pérez-García E, Villanueva-Reza M, Tovar-Méndez VH, Medrano-Borromeo C, Martínez-Valenzuela A, Jandete-Medina MA, Martínez-Guerra BA, Uscanga-Domínguez L, Sifuentes-Osornio J, Ponce-de-León A, Olivas-Martinez A, Moctezuma-Velázquez C. Low thoracic skeletal muscle area is not associated with negative outcomes in patients with COVID-19. Am J Phys Med Rehabil. 2021;100(5):413–418. DOI
Olivas-Martinez A, Cárdenas-Fragoso JL, Jiménez JV, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16(2):e0245772. DOI
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes C, Díaz-Mejía B, Pérez-García E, Olivas-Martinez A, et al. Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study. Rev Invest Clin. 2020;72(3):165–177. DOI

Gastroenterology and Liver Diseases

Ruiz-Manríquez J, Feria-Agudelo SM, Olivas-Martinez A, et al. Granulomatous Liver Disease in a Referral Center in Mexico City. Annals of Hepatology. 2025;102108. DOI
Ruiz-Manriquez J, Olivas-Martinez A, Mier y Teran-Ellis S, et al. Complications in Patients with Surgically Altered Gastrointestinal Anatomy Undergoing Endoscopic Retrograde Cholangiopancreatography: 15-Year Experience at a Tertiary Care Center in Latin America. Dig Dis Sci. 2024. DOI
Fernández-Ramírez A, Olivas-Martinez A, Ruiz-Manriquez J, et al. Posttransplantation diabetes mellitus after liver transplant and the impact of family history of diabetes in a Mexican cohort. Rev Gastroenterol Mex (Eng Ed). 2024;89(2):249–57. DOI
Rodriguez-Rodriguez S, Olivas-Martinez A, Delgado-de la Mora J, Martinez-Benitez B, Garcia-Juarez I, Demichelis-Gomez R. Is iron overload associated with worse outcomes in patients with chronic liver disease undergoing liver transplantation? Rev Invest Clin. 2024;76(1):18–28. DOI
Jiménez-Gutiérrez JM, Alonso-Lárraga JO, Hernández-Guerrero AI, Lino-Silva LS, Olivas-Martinez A. Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study. Ther Adv Gastrointest Endosc. 2023;16. DOI
Catalán R, Jiménez-Ceja JV, Rincón-Pedrero R, Olivas-Martínez A, et al. Factors Associated with Development of Acute Kidney Injury After Liver Transplantation. Rev Invest Clin. 2022;74(2):906. DOI
Gonzalez-Chagolla A, Olivas-Martinez A, et al. Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico Lancet Reg Health Am. 2022;7:100151. DOI
Ruiz-Manriquez J, Olivas-Martinez A, Chávez-García LC, et al. Prevalence of metabolic-associated fatty liver disease in Mexico and development of a screening tool: the MAFLD-S score. Gastro Hep Advances. 2022;1(3):352–358. DOI
Jiménez-Gutiérrez JM, García-Juárez I, Olivas-Martinez A, Ruiz I. One-year outcome of patients with cirrhosis who developed spontaneous bacterial empyema: A cohort study. J Dig Dis. 2021;22(12):714–20. DOI
Kauffman-Ortega E, Ruiz-Manriquez J, Olivas-Martinez A, et al. Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort. Arch Med Res. 2021;52(7):713–718. DOI

Oncology and Hematologic Diseases

Vaca-Cartagena BF, Ferrigno Guajardo AS, Azim HA, Rotolo F, Olivas-Martinez A, et al. Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort. Breast. 2025;79:103866. DOI
Corona-Rodarte E, Olivas-Martinez A, Remolina-Bonilla YA, Domínguez-Cherit JG, Lam ET, Bourlon MT. Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma. Int J Dermatol. 2021;60(10):1242–1247. DOI
Olivas-Martinez A, Corona-Rodarte E, Nuñez-Zuno A, et al. Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City. Blood Res. 2021;56(3):166–174. DOI
Rajme-Lopez S, Crabtree-Ramírez B, Acosta-Medina A, Olivas-Martínez A, Bourlon C. HIV-positive patients presenting with peripheral blood cytopenias: Is bone marrow assessment a priority? Hematol Transfus Cell Ther. 2022;44(4):542–8. DOI
Aguado-Vázquez T, Olivas-Martínez A, Cancino-Ramos U, et al. 18f-Fluorodeoxyglucose Positron Emission Tomography versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients. Rev Invest Clin. 2021;73(2):79–86. DOI
Olivas-Martinez A, Barrales-Benítez O, Montante-Montes-de-Oca D, et al. Epidemiology of polycythemia vera in a Mexican population. Magazine of European Medical Oncology. 2020;13:111–7. DOI

Additional Applied Research

Niembro-Ortega MD, Martinez-Gamboa A, Olivas-Martinez A, et al. Differentiating proven progressive disseminated histoplasmosis from other diagnoses in hospitalized persons with HIV and suspected progressive disseminated histoplasmosis: Findings from a clinical and demographic study in Mexico. PLOS Neglected Tropical Diseases. 2025 Sep 17;19(9):e0013527 DOI.
Braghieri L, Olivas-Martinez A, Silvestri EG, Karatasakis A, Li S, Mahr C, Bravo C. The Impact of the 2018 Allocation System Change on Patients Bridged With Durable Left Ventricular Assist Device: An Updated UNOS Registry Analysis. ASAIO J. 2024;70(5):456–9. DOI
Martínez-Gamboa A, Niembro-Ortega MD, Torres-González P, Santiago-Cruz J, Velázquez-Zavala NG, Rangel-Cordero A, Crabtree-Ramírez B, Gamboa-Domínguez A, Reyes-Gutiérrez E, Reyes-Terán G, Lozano-Fernandez VH, Ahumada-Topete VH, Martínez-Ayala P, Manríquez-Reyes M, Ramírez-Hinojosa JP, Rodríguez-Zulueta P, Hernández-León C, Ruíz-Quiñones J, Rivera-Martínez NE, Chaparro-Sánchez A, Andrade-Villanueva J, González-Hernández LA, Cruz-Martínez S, Flores-Barrientos O, Gaytán-Martínez JE, Magaña-Aquino M, Cervantes-Sánchez A, Olivas-Martínez A, et al. Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in patients living with HIV/AIDS: A prospective multicenter study in Mexico. PLoS Negl Trop Dis. 2021;15(3):e0009215. DOI
Ortiz-Brizuela E, Caro-Vega Y, Bobadilla-del-Valle M, Leal-Vega F, Criollo-Mora E, López-Luis BA, Esteban-Kenel V, Torres-Ventimilla E, Galindo-Fraga A, Olivas-Martínez A, et al. The Influence of Hospital Antimicrobial Use on Carbapenem Non-Susceptible Enterobacterales Incidence Rates According to Their Mechanism of Resistance: A Time-Series Analysis. J Hosp Infect. 2020;105(4):757–65. DOI
Martínez-Rueda AJ, Olivas-Martínez A, Vega-Vega O, Fonseca-Correa JI, Correa-Rotter R. New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline: Healthcare Impact in Mexico and Other Developing Countries. Hypertension. 2019;73(1):142–7. DOI
Vidal-Mayo JJ, Olivas-Martínez A, Pérez-Díaz I, et al. Calculated Versus Measured Urine Osmolarity: Accuracy of Estimated Urine Density. Rev Invest Clin. 2018;70(6):310–8. DOI

Global Burden of Disease Collaborations

GBD 2023 Vaccine Coverage Collaborators. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025 Jul 19. 406(10500), pp.235-260. DOI
GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024 Sep 18. 404(10459):1199–1226. DOI
GBD 2021 Lower Respiratory Infections and AMR Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176-2. DOI
GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;S0140-6736(24)00476-8. DOI
Antimicrobial Resistance Collaborators. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. Lancet Reg Health–Americas. 2023;25:100561. DOI
GBD Fatty Liver Disease SDG Collaborators. The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories. Hepatology. 2023;78(3):911–28. DOI
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. DOI